Pharmaceutical Cold Chain Logistics Market - 2026-2033

June 2026 | 61 pages | ID: PA1E8DEC631EEN
DataM Intelligence

Abstracts

Pharmaceutical Cold Chain Logistics Market reached US$ 22.75 Billion in 2025 and is expected to reach US$ 44.1 billion by 2033, growing with a CAGR of 4.30% during the forecast period 2026-2033.

The Pharmaceutical Cold Chain Logistics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Pharmaceutical Cold Chain Logistics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type

• Vaccines*
• Biopharmaceuticals
• Drugs and Medicines

By Service Type

• Storage*
• Transportation
• Packaging
• Others

By Temperature Range

• Frozen (Below -20°C) *
• Refrigerated (2°C to 8°C)
• Ambient (15°C to 25°C)
• Cryogenic (-150°C)

By Mode of Delivery

• Last-Mile Delivery *
• Hubs-to-Distributor

By End-User

• Pharmaceutical and Biopharmaceutical Companies*
• Biotechnology Companies
• Hospitals and Healthcare Facilities
• Others

Regional Analysis for Pharmaceutical Cold Chain Logistics Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Pharmaceutical Cold Chain Logistics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY PRODUCT TYPE

4.1. Snippet by Service Type
4.2. Snippet by Temperature Range
4.3. Snippet by Mode of Delivery
4.4. Snippet by End-User
4.5. Snippet by Region

5. DYNAMICS

5.1. Impacting Factors
  5.1.1. Drivers
    5.1.1.1. Rising Advancements in Cold Chain Technology
    5.1.1.2. Virtual Control Towers and Real-Time Tracking
    5.1.1.3. XX
  5.1.2. Restraints
    5.1.2.1. Regulatory Challenges
    5.1.2.2. Complications in Pharmaceutical Cold Chain Logistics
    5.1.2.3. XX
  5.1.3. Opportunity
    5.1.3.1. Integration with AI in Pharmaceutical Cold Chain Logistics
    5.1.3.2. XX
  5.1.4. Impact Analysis

6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

6.1. Market Leaders and Pioneers
  6.1.1. Emerging Pioneers and Prominent Players
  6.1.2. Established Leaders with the Largest Marketing Brand
  6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. Regulatory and Reimbursement Landscape
  6.3.1. North America
  6.3.2. Europe
  6.3.3. Asia Pacific
  6.3.4. South America
  6.3.5. Middle East & Africa
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Pricing Analysis and Price Dynamics

7. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  7.1.2. Market Attractiveness Index, By Product Type
7.2. Vaccines*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Biopharmaceuticals
7.4. Drugs and Medicines

8. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY SERVICE TYPE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  8.1.2. Market Attractiveness Index, By Service Type
8.2. Storage*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Transportation
8.4. Packaging
8.5. Others

9. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE RANGE

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  9.1.2. Market Attractiveness Index, By Temperature Range
9.2. Frozen (Below -20°C) *
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Refrigerated (2°C to 8°C)
9.4. Ambient (15°C to 25°C)
9.5. Cryogenic (-150°C)

10. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF DELIVERY

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  10.1.2. Market Attractiveness Index, By Mode of Delivery
10.2. Last-Mile Delivery *
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Hubs-to-Distributor

11. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY END-USER

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.1.2. Market Attractiveness Index, By End-User
11.2. Pharmaceutical and Biopharmaceutical Companies*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Biotechnology Companies
11.4. Hospitals and Healthcare Facilities
11.5. Others

12. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

13. INTRODUCTION

13.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  13.1.1. Market Attractiveness Index, By Region
13.2. North America
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.2.8.1. U.S.
    13.2.8.2. Canada
    13.2.8.3. Mexico
13.3. Europe
  13.3.1. Introduction
  13.3.2. Key Region-Specific Dynamics
  13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.3.8.1. Germany
    13.3.8.2. UK
    13.3.8.3. France
    13.3.8.4. Spain
    13.3.8.5. Italy
    13.3.8.6. Rest of Europe
13.4. Asia-Pacific
  13.4.1. Introduction
  13.4.2. Key Region-Specific Dynamics
  13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.4.8.1. China
    13.4.8.2. India
    13.4.8.3. Japan
    13.4.8.4. South Korea
    13.4.8.5. Rest of Asia-Pacific
13.5. South America
  13.5.1. Introduction
  13.5.2. Key Region-Specific Dynamics
  13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.5.8.1. Brazil
    13.5.8.2. Argentina
    13.5.8.3. Rest of South America
13.6. Middle East and Africa
  13.6.1. Introduction
  13.6.2. Key Region-Specific Dynamics
  13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

15. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

15.1. Market Share Analysis and Positioning Matrix
15.2. Strategic Partnerships, Mergers & Acquisitions
15.3. Key Developments in Product Portfolios and Innovations
15.4. Company Benchmarking

16. COMPANY PROFILES

16.1. Cardinal Health*
  16.1.1. Company Overview
  16.1.2. Product Portfolio
    16.1.2.1. Product Description
    16.1.2.2. Product Key Performance Indicators (KPIs)

17. FINANCIAL OVERVIEW

17.1. Company Revenue
  17.1.1. Geographical Revenue Shares
    17.1.1.1. Revenue Forecasts
  17.1.2. Key Developments
    17.1.2.1. Mergers & Acquisitions
    17.1.2.2. Key Product Development Activities
    17.1.2.3. Regulatory Approvals, etc.
  17.1.3. SWOT Analysis
17.2. AmerisourceBergen Corporation
17.3. Envirotainer AB
17.4. FedEx
17.5. United Parcel Service of America, Inc.
17.6. Thermo King
17.7. Sonoco ThermoSafe
17.8. B Medical Systems India Private Limited
17.9. DoKaSch TEMPERATURE SOLUTIONS GmbH
17.10. Nordic Cold Chain SolutionsLIST NOT EXHAUSTIVE

18. ASSUMPTION AND RESEARCH METHODOLOGY

18.1. Data Collection Methods
18.2. Data Triangulation
18.3. Forecasting Techniques
18.4. Data Verification and Validation

19. APPENDIX

19.1. About Us and Services
19.2. Contact Us